Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 471 to 480 of 1525

TitleReference numberPublishedLast updated
Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancerTA812
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitorsTA813
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitisTA814
Fever in under 5sQS64
Urinary tract infection in children and young peopleQS36
Transcatheter tricuspid valve leaflet repair for tricuspid regurgitationHTG632
PLGF-based testing to help diagnose suspected preterm pre-eclampsiaHTG630
Transcatheter tricuspid valve annuloplasty for tricuspid regurgitationHTG631
Duvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal)TA811
Urinary tract infection in under 16s: diagnosis and managementNG224

Results per page

  1. 10
  2. 25
  3. 50
  4. All